Crohn’s Disease: Surgical Management

  • Scott A. Strong


Crohn’s disease is a chronic, unremitting inflammatory ­condition of uncertain etiology that can affect the entirety of the alimentary tract. Appropriate diagnosis and management of the disease requires collaboration among physicians, radio­logists, pathologists, and surgeons who work to safely maintain a satisfactory quality of life in patients who suffer from this incurable disorder. Depending upon the patient age, disease location, disease behavior, and other clinical parameters, the surgeon uses intestinal bypass, strictureplasty, and/or bowel resection to manage disease that is confounded by complications or refractory to conventional medical therapy. Particular care must be taken during surgery to address all areas of symptomatic disease while minimizing the risk for future complications arising from recurrent disease.


  1. 1.
    Economou M, Pappas G. New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–20.PubMedGoogle Scholar
  2. 2.
    Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol. 2004;18:463–79.PubMedGoogle Scholar
  3. 3.
    Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.PubMedGoogle Scholar
  4. 4.
    Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–9.PubMedGoogle Scholar
  5. 5.
    Melum E, Franke A, Karlsen TH. Genome-wide association studies – a summary for the clinical gastroenterologist. World J Gastroenterol. 2009;15:5377–96.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40:955–62.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol. 2010;45:9–16.PubMedGoogle Scholar
  8. 8.
    Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–71.PubMedGoogle Scholar
  9. 9.
    Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, et al. Effect of fecal diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet. 1991;338:771–4.PubMedGoogle Scholar
  10. 10.
    Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol. 2004;18:497–508.PubMedGoogle Scholar
  11. 11.
    Jantchou P, Monnet E, Carbonnel F. Environmental risk factors in Crohn’s disease and ulcerative colitis (excluding tobacco and appendicectomy). Gastroentérol Clin Biol. 2006;30:859–67.PubMedGoogle Scholar
  12. 12.
    Farmer RG, Hawk WA, Turnbull RB. Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology. 1975;68:627–35.PubMedGoogle Scholar
  13. 13.
    Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8–15.PubMedGoogle Scholar
  14. 14.
    Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5–36.Google Scholar
  15. 15.
    Fedorak RN. Is it time to re-classify Crohn’s disease? Best Pract Res Clin Gastroenterol. 2004;18 Suppl:99–106.Google Scholar
  16. 16.
    Papi C, Festa V, Fagnani C, Stazi A, Antonelli G, Moretti A, et al. Evolution of clinical behaviour in Crohn’s disease: predictive factors of penetrating complications. Dig Liver Dis. 2005;37:247–53.PubMedGoogle Scholar
  17. 17.
    Pikarsky AJ, Gervaz P, Wexner SD. Perianal Crohn disease: a new scoring system to evaluate and predict outcome of surgical intervention. Arch Surg. 2002;137:774–7.PubMedGoogle Scholar
  18. 18.
    Stange EF, Travis SP, Vermeire S, European Crohn’s and Colitis Organisation, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut. 2006;55 Suppl 1:1–15.Google Scholar
  19. 19.
    Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol. 1997;9:353–9.PubMedGoogle Scholar
  20. 20.
    Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol. 2000;95:359–67.PubMedGoogle Scholar
  21. 21.
    Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:661–5.PubMedGoogle Scholar
  22. 22.
    Sachar DB, Luppescu NE, Bodian C, Shlien RD, Fabry TL, Gumaste VV. Erythrocyte sedimentation as a measure of Crohn’s disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol. 1990;12:643–6.PubMedGoogle Scholar
  23. 23.
    Huprich JE, Rosen MP, Fidler JL, Gay SB, Grant TH, Greene FL, et al. ACR Appropriateness Criteria on Crohn’s disease. J Am Coll Radiol. 2010;7:94–102.PubMedGoogle Scholar
  24. 24.
    Peyrin-Biroulet L, Loftus Jr EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–97.PubMedGoogle Scholar
  25. 25.
    Dhillon SL, Loftus Jr EV, Tremaine WJ, et al. The natural history of surgery for Crohn’s disease in a population-based cohort from Olmsted County, Minnesota. Am J Gastroenterol. 2005;100:S305.Google Scholar
  26. 26.
    Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T. Overall and cause-specific mortality in Crohn’s disease: a meta-analysis of population-based studies. Inflamm Bowel Dis. 2010;16:347–53.PubMedGoogle Scholar
  27. 27.
    Korzenik JR. Massive lower gastrointestinal hemorrhage in Crohn’s disease. Curr Treat Options Gastroenterol. 2000;3:211–6.PubMedGoogle Scholar
  28. 28.
    Kazama Y, Watanabe T, Akahane M, Yoshioka N, Ohtomo K, Nagawa H. Crohn’s disease with life-threatening hemorrhage from terminal ileum: successful control by superselective arterial embolization. J Gastroenterol. 2005;40:1155–7.PubMedGoogle Scholar
  29. 29.
    Fazio VW, Zelas P, Weakley FL. Intraoperative angiography and the localization of bleeding from the small intestine. Surg Gynecol Obstet. 1980;151:637–40.PubMedGoogle Scholar
  30. 30.
    Werbin N, Haddad R, Greenberg R, Karin E, Skornick Y. Free perforation in Crohn’s disease. Isr Med Assoc J. 2003;5:175–7.PubMedGoogle Scholar
  31. 31.
    Greenstein AJ, Sachar DB, Mann D, Lachman P, Heimann T, Aufses Jr AH. Spontaneous free perforation and perforated abscess in 30 patients with Crohn’s disease. Ann Surg. 1987;205:72–6.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Bundred NJ, Dixon JM, Lumsden AB, Gilmour HM, Davies GC. Free perforation in Crohn’s colitis. A ten-year review. Dis Colon Rectum. 1985;28:35–7.PubMedGoogle Scholar
  33. 33.
    Santos JV, Baudet JA, Casellas FJ, Guarner LA, Vilaseca JM, Malagelada JR. Intravenous cyclosprine for steroid-refractory attacks of Crohn’s disease. Short- and long-term results. J Clin Gastroenterol. 1995;20:207–10.PubMedGoogle Scholar
  34. 34.
    Sheth SG, LaMont JT. Toxic megacolon. Lancet. 1998;351:509–13.PubMedGoogle Scholar
  35. 35.
    Lichtenstein GR, Hanauer SB, Practice Parameters Committee of American College of Gastroenterology. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104:465–83.PubMedGoogle Scholar
  36. 36.
    Yamamoto T, Keighley MR. Long-term outcome of total colectomy and ileostomy for Crohn disease. Scand J Gastroenterol. 1999;34:280–6.PubMedGoogle Scholar
  37. 37.
    Lavery IC, Jagelman DG. Cancer in the excluded rectum following surgery for inflammatory bowel disease. Dis Colon Rectum. 1982;25:522–4.PubMedGoogle Scholar
  38. 38.
    Guillem JG, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC, Schoetz Jr DJ. Factors predictive of persistent or recurrent Crohn’s disease in excluded rectal segments. Dis Colon Rectum. 1992;35:768–72.PubMedGoogle Scholar
  39. 39.
    Scott HW, Sawyers JL, Gobbel Jr WG, Graves HA, Shull HW. Surgical management of toxic dilatation of the colon in ulcerative colitis. Ann Surg. 1974;179:647–56.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Koudahl G, Kristensen M. Toxic megacolon in ulcerative colitis. Scand J Gastroenterol. 1975;10:417–21.PubMedGoogle Scholar
  41. 41.
    Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–22.PubMedGoogle Scholar
  42. 42.
    Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut. 2006;55 Suppl 1:i36–58.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn’s disease: pathogenesis and interventions. Inflamm Bowel Dis. 2007;13:620–8.PubMedGoogle Scholar
  44. 44.
    Savage MO, Beattie RM, Camacho-Hubner C, Walker-Smith JA, Sanderson IR. Growth in Crohn’s disease. Acta Paediatr Suppl. 1999;88:89–92.PubMedGoogle Scholar
  45. 45.
    von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.Google Scholar
  46. 46.
    Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn’s colitis. Gastroenterology. 2001;120:820–6.PubMedGoogle Scholar
  47. 47.
    Friedman S, Rubin PH, Bodian C, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn’s colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008;6:993–8.PubMedGoogle Scholar
  48. 48.
    Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale – update based on new evidence. Gastroenterology. 2003;124:544–60.PubMedGoogle Scholar
  49. 49.
    Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–21.PubMedGoogle Scholar
  50. 50.
    Byrne CM, Solomon MJ, Young JM, Selby W, Harrison JD. Patient preferences between surgical and medical treatment in Crohn’s disease. Dis Colon Rectum. 2007;50:586–97.PubMedGoogle Scholar
  51. 51.
    Otterson MF, Lundeen SJ, Spinelli KS, Sudakoff GS, Telford GL, Hatoum OA, et al. Radiographic underestimation of small bowel stricturing Crohn’s disease: a comparison with surgical findings. Surgery. 2004;136:854–60.PubMedGoogle Scholar
  52. 52.
    Young-Fadok TM, Wolff BG, Meagher A, Benn PL, Dozois RR. Surgical management of ileosigmoid fistulas in Crohn’s disease. Dis Colon Rectum. 1997;40:558–61.PubMedGoogle Scholar
  53. 53.
    Melton GB, Fazio VW, Kiran RP, He J, Lavery IC, Shen B, et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn’s disease: pouch retention and implications of delayed diagnosis. Ann Surg. 2008;248:608–16.PubMedGoogle Scholar
  54. 54.
    Fazio VW, Marchetti F, Church J, Goldblum J, Lavery I, Hull T, et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224:563–73.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg. 2000;24:1258–62.PubMedGoogle Scholar
  56. 56.
    van Dongen LM, Lubbers EJC. Perianal fistulas in patients with Crohn’s disease. Arch Surg. 1986;121:1187–90.PubMedGoogle Scholar
  57. 57.
    Katariya RN, Sood S, Rao PG, Rao PL. Stricture-plasty for tubercular strictures of the gastro-intestinal tract. Br J Surg. 1977;64:496–8.PubMedGoogle Scholar
  58. 58.
    Lee ECG, Papaioannou N. Minimal surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl. 1982;64:229–33.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD. Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum. 2000;43:911–9.PubMedGoogle Scholar
  60. 60.
    Dietz DW, Laureti S, Strong SA, Hull TL, Church J, Remzi FH, et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001;192:330–7.PubMedGoogle Scholar
  61. 61.
    Reese GE, Purkayastha S, Tilney HS, von Roon A, Yamamoto T, Tekkis PP. Strictureplasty vs. resection in small bowel Crohn’s disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis. 2007;9:686–94.PubMedGoogle Scholar
  62. 62.
    Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007;50:1968–86.PubMedGoogle Scholar
  63. 63.
    Yamamoto T, Allan RN, Keighley MR. Long-term outcome of surgical management for diffuse jejunoileal Crohn’s disease. Surgery. 2001;129:96–102.PubMedGoogle Scholar
  64. 64.
    Michelassi F, Taschieri A, Tonelli F, Sasaki I, Poggioli G, Fazio V, et al. An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum. 2007;50:277–84.PubMedGoogle Scholar
  65. 65.
    Menon AM, Mirza AH, Moolla S, Morton DG. Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn’s disease: report of a case. Dis Colon Rectum. 2007;50:257–9.PubMedGoogle Scholar
  66. 66.
    Ozuner G, Fazio VW. Management of gastrointestinal hemorrhage after strictureplasty for Crohn’s disease. Dis Colon Rectum. 1995;38:297–300.PubMedGoogle Scholar
  67. 67.
    Tjandra JJ, Fazio VW. Strictureplasty for ileocolic anastomotic strictures in Crohn’s disease. Dis Colon Rectum. 1993;36:1099–103.PubMedGoogle Scholar
  68. 68.
    Sampietro GM, Cristaldi M, Maconi G, Parente F, Sartani A, Ardizzone S, et al. A prospective, longitudinal study of nonconventional strictureplasty in Crohn’s disease. J Am Coll Surg. 2004;199:8–20.PubMedGoogle Scholar
  69. 69.
    Futami K, Arima S. Role of strictureplasty in surgical treatment of Crohn’s disease. J Gastroenterol. 2005;40 Suppl 16:35–9.PubMedGoogle Scholar
  70. 70.
    Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum. 2007;50:1674–87.PubMedGoogle Scholar
  71. 71.
    Choy PY, Bissett IP, Docherty JG, Parry BR, Merrie AE. Stapled versus handsewn methods for ileocolic anastomoses. Cochrane Database Syst Rev. 2007:CD004320.Google Scholar
  72. 72.
    McLeod RS, Wolff BG, Ross S, Parkes R, Investigators of the CAST Trial. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009;52:919–27.PubMedGoogle Scholar
  73. 73.
    Poggioli G, Stocchi L, Laureti S, Selleri S, Marra C, Magalotti C, et al. Conservative surgical management of terminal ileitis: side-to-side enterocolic anastomosis. Dis Colon Rectum. 1997;40:234–7.PubMedGoogle Scholar
  74. 74.
    Tilney HS, Constantinides VA, Heriot AG, Nicolaou M, ­Athanasiou T, Ziprin P, et al. Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis. Surg Endosc. 2006;20:1036–44.PubMedGoogle Scholar
  75. 75.
    Wu JS, Birnbaum EH, Kodner IJ, Fry RD, Read TE, Fleshman JW. Laparoscopic-assisted ileocolic resections in patients with Crohn’s disease: are abscesses, phlegmons, or recurrent disease contraindications? Surgery. 1997;122:682–8.PubMedGoogle Scholar
  76. 76.
    Evans J, Poritz L, MacRae H. Influence of experience on laparoscopic ileocolic resection for Crohn’s disease. Dis Colon Rectum. 2002;45:1595–600.PubMedGoogle Scholar
  77. 77.
    Goyer P, Alves A, Bretagnol F, Bouhnik Y, Valleur P, Panis Y. Impact of complex Crohn’s disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients. Dis Colon Rectum. 2009;52:205–10.PubMedGoogle Scholar
  78. 78.
    Lowney JK, Dietz DW, Birnbaum EH, Kodner IJ, Mutch MG, Fleshman JW. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn’s disease compared with conventional surgery? A long-term, follow-up study. Dis Colon Rectum. 2006;49:58–63.PubMedGoogle Scholar
  79. 79.
    Eshuis EJ, Polle SW, Slors JF, Hommes DW, Sprangers MA, Gouma DJ, et al. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn’s disease: a comparative study. Dis Colon Rectum. 2008;51:858–67.PubMedPubMedCentralGoogle Scholar
  80. 80.
    Stocchi L, Milsom JW, Fazio VW. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn’s ­disease: follow-up of a prospective randomized trial. Surgery. 2008;144:622–7.PubMedGoogle Scholar
  81. 81.
    Tekkis PP, Purkayastha S, Lanitis S, Athanasiou T, Heriot AG, Orchard TR, et al. A comparison of segmental vs. subtotal/total colectomy for colonic Crohn’s disease: a meta-analysis. Colorectal Dis. 2006;8:82–90.PubMedGoogle Scholar
  82. 82.
    Harold KL, Pollinger H, Matthews BD, Kercher KW, Sing RF, Heniford BT. Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries. Surg Endosc. 2003;17:1228–30.PubMedGoogle Scholar
  83. 83.
    da Luz Moreira A, Stocchi L, Remzi FH, Geisler D, Hammel J, Fazio VW. Laparoscopic surgery for patients with Crohn’s colitis: a case-matched study. J Gastrointest Surg. 2007;11:1529–33.PubMedGoogle Scholar
  84. 84.
    Broering DC, Eisenberger CF, Koch A, Bloechle C, Knoefel WT, Durig M, et al. Strictureplasty for large bowel stenosis in Crohn’s disease: quality of life after surgical therapy. Int J Colorectal Dis. 2001;16:81–7.PubMedGoogle Scholar
  85. 85.
    Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH, Greenstein AJ. Malignant strictures in Crohn’s disease. Am J Gastroenterol. 1991;86:882–5.PubMedGoogle Scholar
  86. 86.
    Keighley MRB, Buchmann P, Lee JR. Assessment of anorectal function in selection of patients for ileo-rectal anastomosis in Crohn’s colitis. Gut. 1982;23:102–7.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Kariv Y, Remzi FH, Strong SA, Hammel JP, Preen M, Fazio VW. Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn’s proctocolitis patients. J Am Coll Surg. 2009;208:390–9.PubMedGoogle Scholar
  88. 88.
    Cirincione E, Gorfine SR, Bauer JJ. Is Hartmann’s procedure safe in Crohn’s disease? Report of three cases. Dis Colon Rectum. 2000;43:544–7.PubMedGoogle Scholar
  89. 89.
    Rius J, Nessim A, Nogueras JJ, Wexner SD. Gracilis transposition in complicated perianal fistula and unhealed perineal wounds in Crohn’s disease. Eur J Surg. 2000;166:218–22.PubMedGoogle Scholar
  90. 90.
    Hurst RD, Gottlieb LJ, Crucitti P, Melis M, Rubin M, Michelassi F. Primary closure of complicated perineal wounds with myocutaneous and fasciocutaneous flaps after proctectomy for Crohn’s disease. Surgery. 2001;130:767–72.PubMedGoogle Scholar
  91. 91.
    Yamamoto T, Mylonakis E, Keighley MR. Omentoplasty for persistent perineal sinus after proctectomy for Crohn’s disease. Am J Surg. 2001;181:265–7.PubMedGoogle Scholar
  92. 92.
    Regimbeau JM, Panis Y, Pocard M, Bouhnik Y, Lavergne-Slove A, Rufat P, et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn’s disease. Dis Colon Rectum. 2001;44:769–78.PubMedGoogle Scholar
  93. 93.
    Sagar PM, Dozois RR, Wolff BG. Long-term results of ileal pouch-anal anastomosis in patients with Crohn’s disease. Dis Colon Rectum. 1996;39:893–8.PubMedGoogle Scholar
  94. 94.
    Mylonakis E, Allan RN, Keighley MR. How does pouch construction for a final diagnosis of Crohn’s disease compare with ileoproctostomy for established Crohn’s proctocolitis? Dis Colon Rectum. 2001;44:1137–42.PubMedGoogle Scholar
  95. 95.
    Braveman JM, Schoetz Jr DJ, Marcello PW, Roberts PL, Coller JA, Murray JJ, et al. The fate of the ileal pouch in patients developing Crohn’s disease. Dis Colon Rectum. 2004;47:1613–9.PubMedGoogle Scholar
  96. 96.
    Cooke WT, Swan CH. Diffuse jejunoileitis of Crohn’s disease. Quart J Med. 1974;72:583–601.Google Scholar
  97. 97.
    Nugent FW, Roy MA. Duodenal Crohn’s disease: an analysis of 89 cases. Am J Gastroenterol. 1989;84:249–54.PubMedGoogle Scholar
  98. 98.
    Cary ER, Tremaine WJ, Banks PM, Nagorney DM. Case report: isolated Crohn’s disease of the stomach. Mayo Clin Proc. 1989;64:776–9.PubMedGoogle Scholar
  99. 99.
    Poggioli G, Stocchi L, Laureti S, Selleri S, Marra C, Salone MC, et al. Duodenal involvement of Crohn’s disease: three different clinicopathologic patterns. Dis Colon Rectum. 1997;40:179–83.PubMedGoogle Scholar
  100. 100.
    Kimura H, Sugita A, Nishiyama K, Shimada H. Treatment of duodenal Crohn’s disease with stenosis: case report of 6 cases. Nippon Shokakibyo Gakkai Zasshi. 2000;9:697–702.Google Scholar
  101. 101.
    Eisenberger CF, Izbicki JR, Broering DC, Bloechle C, Steffen M, Hosch SB, et al. Strictureplasty with a pedunculated jejunal patch in Crohn’s disease of the duodenum. Am J Gastroenterol. 1998;93:267–9.PubMedGoogle Scholar
  102. 102.
    Worsey MJ, Hull T, Ryland L, Fazio V. Strictureplasty is an effective option in the operative management of duodenal Crohn’s disease. Dis Colon Rectum. 1999;42:596–600.PubMedGoogle Scholar
  103. 103.
    Yamamoto T, Bain IM, Connolly AB, Allan RN, Keighley MR. Outcome of strictureplasty for duodenal Crohn’s disease. Br J Surg. 1999;86:259–62.PubMedGoogle Scholar
  104. 104.
    Tonelli F, Bargellini T, Leo F, Nesi G. Duodenal adenocarcinoma arising at the strictureplasty site in a patient with Crohn’s disease: report of a case. Int J Colorectal Dis. 2009;24:475–7.PubMedGoogle Scholar
  105. 105.
    Hughes LE. Clinical classification of perianal Crohn’s disease. Dis Colon Rectum. 1992;35:928–32.PubMedGoogle Scholar
  106. 106.
    Spradlin NM, Wise PE, Herline AJ, Muldoon RL, Rosen M, Schwartz DA. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn’s perianal fistulas. Am J Gastroenterol. 2008;103:2527–35.PubMedGoogle Scholar
  107. 107.
    Schaefer O, Lohrmann C, Langer M. Assessment of anal fistulas with high-resolution subtraction MR-fistulography: comparison with surgical findings. J Magn Reson Imaging. 2004;19:91–8.PubMedGoogle Scholar
  108. 108.
    Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001;121:1064–72.PubMedGoogle Scholar
  109. 109.
    Wise PE, Schwartz DA. Related management of perianal Crohn’s disease. Clin Gastroenterol Hepatol. 2006;4:426–30.PubMedGoogle Scholar
  110. 110.
    Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn’s disease. Aliment Pharmacol Ther. 2003;18:1113–20.PubMedGoogle Scholar
  111. 111.
    Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med. 1999;340:1398–405.PubMedGoogle Scholar
  112. 112.
    Thomas M, Bienkowski R, Vandermeer TJ, Trostle D, Cagir B. Malignant transformation in perianal fistulas of Crohn’s disease: a systematic review of literature. J Gastrointest Surg. 2010;14:66–73.PubMedGoogle Scholar
  113. 113.
    Kamm MA, Ng SC. Perianal fistulizing Crohn’s disease: a call to action. Clin Gastroenterol Hepatol. 2008;6(1):7–10.PubMedGoogle Scholar
  114. 114.
    Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98–103.PubMedGoogle Scholar
  115. 115.
    Vitton V, Gasmi M, Barthet M, Desjeux A, Orsoni P, Grimaud JC. Long-term healing of Crohn’s anal fistulas with fibrin glue injection. Aliment Pharmacol Ther. 2005;21:1453–7.PubMedGoogle Scholar
  116. 116.
    Safar B, Jobanputra S, Sands D, Weiss EG, Nogueras JJ, Wexner SD. Anal fistula plug: initial experience and outcomes. Dis Colon Rectum. 2009;52:248–52.PubMedGoogle Scholar
  117. 117.
    O’Connor L, Champagne BJ, Ferguson MA, Orangio GR, Schertzer ME, Armstrong DN. Efficacy of anal fistula plug in closure of Crohn’s anorectal fistulas. Dis Colon Rectum. 2006;49:1569–73.PubMedGoogle Scholar
  118. 118.
    Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME. Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum. 2007;50:2067–74.PubMedGoogle Scholar
  119. 119.
    Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative ­recurrence of Crohn’s disease. Cochrane Database Syst Rev. 2009:CD006873.Google Scholar
  120. 120.
    Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136:441–50.PubMedGoogle Scholar
  121. 121.
    Strong SA, Koltun WA, Hyman NH, Buie WD, Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the surgical management of Crohn’s disease. Dis Colon Rectum. 2007;50:1735–46.PubMedGoogle Scholar

Copyright information

© ASCRS (American Society of Colon and Rectal Surgeons) 2011

Authors and Affiliations

  • Scott A. Strong
    • 1
  1. 1.Department of Colon and Rectal SurgeryCleveland Clinic FoundationClevelandUSA

Personalised recommendations